Search Results - "Beniashvili, A G"

Effects of Blockade of Cholinesterase on Negative Disorders in Schizophrenia by Morozova, M. A., Potanin, S. S., Rupchev, G. E., Burminskiy, D. S., Lepilkina, T. A., Beniashvili, A. G.

“…Objective. To assess the possible influence of blockade of cholinesterase on negative disorders in schizophrenia patients. Materials and methods. The study…”
Get full text

Management of a Female Patient with Irritable Bowel Syndrome and Somatoform Disorder by Trush, E. A., Poluektova, E. A., Beniashvili, A. G., Shifrin, O. S.

“…Aim: to demonstrate the management of a patient with somatization disorder and irritable bowel syndrome. Key points. A 41-yo female patient was admitted with…”
Get full text

Cognitive impairment in chronic heart failure. How new therapeutic options for the treatment of chronic heart failure affect cognitive function? by Aksenova, Y. O., Osmolovskaya, Y. F., Petrukhina, A. A., Zhirov, I. V., Beniashvili, A. G., Tereshchenko, S. N., Morozova, M. A.

“…Heart failure is a serious chronic illness and a global healthcare problem. Patients with heart failure have increased hospital readmission rates and mortality…”
Get full text

Nutraceuticals and Pharmaceuticals by Poluektova, E. A., Beniashvili, A. G., Maslennikov, R. V.

“…Aim. To provide a definition and classification of nutraceutical products and to show their significane in modern integrative medicine. Background…”
Get full text

Development and Validation of a Method for the Quantitative Determination of Etoricoxib in Liquid Dosage Form by Amandusova, A. Kh, Kovalenko, A. E., Morozov, A. V., Savelyeva, K. R., Batalova, T. L., Ostapyuk, O. A., Persanova, L. V., Andreevicheva, T. Yu, Beniashvili, A. G., Shestakov, V. N., Polyakov, S. V.

“…Introduction. Etoricoxib is a selective cyclooxygenase (COX-2) inhibitor used for the treatment of acute pain and has anti-inflammatory and analgesic efficacy…”
Get full text

The Effectiveness of Add-on Treatment with Nutraceutical by Ivashkin, V. T., Morozova, M. A., Poluektova, E. A., Shifrin, O. S., Beniashvili, A. G., Rupchev, G. E., Alekseev, A. A., Poluektov, Yu. M., Mamieva, Z. A., Kovaleva, A. L., Ulyanin, A. I., Trush, E. A.

“…Aim: evaluation of the effectiveness of the nutraceutical “Standard Zdorovia: Gastro” (“SZ Gastro”) in the treatment of patients with irritable bowel syndrome…”
Get full text

Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases by Mayevskaya, M. V., Morozova, M. A., Beniashvili, A. G., Lunkov, V. D., Ivashkin, V. T.

“…Over the period after an exacerbation of chronic liver diseases, patients often retain common symptoms (weakness or fatigue, bad mood, sleep disorder,…”
Get full text

Diagnosis and Treatment of Irritable Bowel Syndrome: Clinical Recommendations of the Russian Gastroenterological Association and Association of Coloproctologists of Russia by Ivashkin, V. T., Maev, I. V., Shelygin, Yu. A., Baranskaya, E. K., Belous, S. S., Belousova, E. A., Beniashvili, A. G., Vasilyev, S. V., Veselov, A. V., Grigoryev, E. G., Kostenko, N. V., Kashnikov, V. N., Kulikovskiy, V. F., Loranskaya, I. D., Lyashenko, O. S., Poluektova, E. A., Rumyantsev, V. G., Timerbulatov, V. M., Fomenko, O. Yu, Khubezov, D. A., Chashkova, E. Yu, Chibisov, G. I., Shapina, M. V., Sheptulin, A. A., Shifrin, O. S., Trukhmanov, A. S., Alekseeva, O. P., Alekseenko, S. A., Baranovsky, A. Yu, Zolnikova, O. Yu, Korochanskaya, N. V., Mammayev, S. N., Khlynov, I. B., Tsukanov, V. V.

“…Aim . Current clinical recommendations accentuate current methods for the diagnosis and treatment of irritable bowel syndrome (IBS). Key points. IBS is a…”
Get full text

Antioxidants in the Treatment of Chronic Diffuse Liver Diseases (the Results of the “MAXAR” Observational Program) by Mayevskaya, M. V., Ivashkin, V. T., Lunkov, V. D., Kryzhanovskiy, S. P., Pirogova, I. Yu, Pavlov, Ch. S., Zharkova, M. S., Beniashvili, A. G., Morozova, M. A.

“…In the Russian Federation, liver diseases are most frequently represented by two their nosological forms, i.e., nonalcoholic and alcoholic fatty liver disease…”
Get full text

Parameters of platelet serotonin system in patients with schizophrenia treated with olanzapine: a search for the serotonergic predictors of therapeutic efficacy by Brusov, O S, Faktor, M I, Zlobina, G P, Dupin, A M, Katasonov, A B, Kartseva, N K, Beniashvili, A G, Zharkova, N B, Rubashkina, V V, Morozova, M A

“…Fifty-nine patients, 21 women and 38 men, with ICD-10 diagnosis of schizophrenia (F20.0), attack-like type, were treated with olanzapine during 28 weeks…”
Get more information

Platelet peculiarities in chronic schizophrenic patients by Zlobina, G P, Brusov, O S, Morozova, M A, Beniashvili, A G

“…A comparative study of the platelet resistance to different effects was conducted in patients with chronic schizophrenia and healthy controls using column…”
Get more information

Effects of the anticholinesterase drug neuromidin in patients with schizophrenia with marked neurocognitive deficits by Morozova, M A, Beniashvili, A G, Rupchev, G E, Lepilkina, T A, Starostin, D S, Brusov, O S

“…An objective of the study was to investigate the effectiveness of neuromidin in stable schizophrenic patients with predominance of symptoms of pseudoorganic…”
Get more information

Effectiveness of a virtual reality relaxation to correct symptoms of depression, anxiety, emotional and cognitive disorders in patients with heart failure by Yu. F. Osmolovskaya, A. A. Petrukhina, Yu. O. Aksenova, I. V. Zhirov, A. G. Beniashvili, M. A. Morozova, S. N. Tereshchenko

“…Aim. To study the effectiveness of virtual reality (VR) relaxation to correct symptoms of depression, anxiety, emotional and cognitive disorders in patients…”
Get full text

Platelet serotonergic parameters and clinical symptoms of psychosis in patients with episodic progressive schizophrenia by Brusov, O S, Faktor, M I, Zlobina, G P, Dupin, A M, Katasonov, A B, Dmitriev, A D, Pavlova, E V, Beniashvili, A G, Morozova, M A

“…A sample included 59 patients, 38 males and 21 females, mean age (M+/-SD) 33,4+/-10,2 years, age-at-onset 26+/-9,5 years, illness duration 7,8+/-6,1 years,…”
Get more information

Guideline for the use of therapeutic drug monitoring of antipsychotics to individualize the selection of therapy in the treatment of exacerbation of schizophrenia by Potanin, S. S., Morozova, M. M., Beniashvili, A. G., Burminskiy, D. S., Miroshnichenko, I. I.

“…Significant individual variability in the concentration of antipsychotics (AP) and its impact on both the efficacy and safety of therapy has been shown in many…”
Get full text

Barth syndrome in an adult patient: an overview of the problem and case report. A review by Muksinova, M D, Osmolovskaya, Y F, Leontyeva, I V, Galaeva, M A, Stukalova, O V, Beniashvili, A G, Safiullina, A A, Zhirov, I V, Tereshchenko, S N

“…Barth syndrome is a rare genetic disease caused by abnormal cardiolipin metabolism, characterized by high mortality within 5 years of diagnosis due to heart…”
Get full text

An effect of cholinesterase blockade on negative symptoms in schizophrenia by Morozova, M A, Potanin, S S, Rupchev, G E, Burminskiy, D S, Lepilkina, T A, Beniashvili, A G

“…Abstruct. To assess the possibilities of influencing the severity of negative disorders in schizophrenic patients with cholinesterase blockade. The study…”
Get more information

Efficacy of drugs most commonly prescribed at functional gastrointestinal diseases (functional dyspepsia syndrome and irritable bowel syndrome) observational study results by Ivashkin, V.T., Poluektova, Ye.A., Reykhart, D.V., Shifrin, O.S., Beniashvili, A.G., Lyashenko, O.S., Belostotsky, A.V.

“…Aim of investigation. To estimate the frequency of prescription of motility regulators and probiotics in the functional gastrointestinal diseases. To define…”
Get full text

Dysphoric spectrum of emotional disorders at irritable bowel syndrome by Morozova, M.A., Rupchev, G.Ye, Alekseyev, A.A., Beniashvili, A.G., Mayevskaya, M.V., Poluektova, Ye.A., Okhlobystina, O.Z., Ivashkin, V.T.

“…Aim of review. The role of emotional disorders of dysphoric range (irritability, strain, hostility etc.) in clinical presentation of the irritable bowel…”
Get full text

Diagnosis and treatment of the irritable bowel syndrome: clinical guidelines of the Russian gastroenterological association and Russian association of coloproctology by V. T. Ivashkin, Yu. A. Shelygin, Ye. K. Baranskaya, Ye. A. Belousova, A. G. Beniashvili, S. V. Vasilyev, A. O. Golovenko, O. V. Golovenko, Ye. G. Grigoryev, N. V. Kostenko, T. L. Lapina, I. D. Loranskaya, O. S. Lyashenko, I. V. Mayev, Ye. A. Poluektova, V. G. Rumyantsev, V. M. Timerbulatov, A. S. Trukhmanov, O. Yu. Fomenko, I. L. Khalif, E. Yu. Chashkova, A. A. Sheptulin, O. S. Shifrin, V. V. Yanovoy

“…Aim of publication. To present recent RGA evidencebased medicine centered guidelines on diagnosis, rational pharmacotherapy and management of irritable bowel…”
Get full text